Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy

By Banna Giuseppe Luigi   Aversa Savina Maria Luciana   Cattelan Anna Maria   Crivellari Gino   Monfardini Silvio  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 2, 2004-02 ,pp. : 155-157

Informa Healthcare

Access to resources Recommend Favorite

Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan

By Khuri-Bulos Najwa   Williams John V.   Shehabi Asem A.   Faouri Samir   Jundi Ehsan Al   Abushariah Omar   Chen Qingxia   Ali S. Asad   Vermund Sten   Halasa Natasha B.  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 5, 2010-04 ,pp. : 368-374

Informa Healthcare

Access to resources Recommend Favorite

Risk of respiratory syncytial virus infection in infants with congenital cystic lung disease

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : 253-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Similar Cytokine Profiles in Response to Infection with Respiratory Syncytial Virus Type A and Type B in the Upper Respiratory Tract in Infants

By  

Intervirology, Vol. 51, Iss. 2, 2008-05 ,pp. : 112-115

Karger

Access to resources Recommend Favorite

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32––35 weeks: a Canadian-based analysis**

By Lanctôôt Krista L.   Masoud Shababa T.   Paes Bosco A.   Tarride Jean-Eric   Chiu Aaron   Hui Charles   Francis Philip L.   Oh Paul I.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3223-3237

Informa Healthcare

Access to resources Recommend Favorite